History

Since its formation in 1997, TECHNOPATH has grown exponentially through its distribution business in the UK & Ireland. In September 2005, TECHNOPATH opened an R&D facility and created a development plan to construct and maintain an ISO 13485 compliant manufacturing facility for the purpose of producing medical devices. These devices include plasma components, quality controls, calibrators and proficiency sera for the clinical diagnostics and bioprocessing industries.  

Following an extensive research and development program, we have developed a range of high quality specific components derived from freshly frozen human plasma, for the manufacture of liquid stable control materials. Utilising proprietary technology, these components have facilitated the production of a series of highly innovative liquid stable quality control products for immunoassay, chemistry and immunology to fulfil the demands of a rapidly evolving clinical diagnostics industry. This division compliments our already established presence in the clinical diagnostics market and facilitates enormous enhancement of the quality and versatility of TECHNOPATH’s products and services, thus further augmenting the reputation of the company whilst providing a basis for expansion and growth in an ever increasing world-wide market.